ATOS Latest Headlines

VTI ETF Inflows Hold Steady Despite AI Sell-Off – 2/24/26

at www.tipranks.com (Tue, 24-Feb 9:04 AM)

FDA Greenlights Atossa’s (Z)-Endoxifen Study, Advancing Hope for Metastatic Breast Cancer Treatment

Market Chameleon (Tue, 6-Jan 11:48 AM)

Atossa Therapeutics Secures FDA Rare Pediatric Disease Designation for (Z)-Endoxifen, Opening Door to Priority Review Voucher Opportunity

Market Chameleon (Thu, 11-Dec 10:35 AM)